Cargando…
Dermlep Study Part 3: Post-RFT Events in Leprosy Patients Presenting to Dermatologists
INTRODUCTION: Presently the leprosy program has no defined surveillance protocols for patients who complete the fixed duration multidrug therapy and are released from treatment (RFT). Hence, the information about the post-RFT events in these patients is sparse and qualitative and quantitative data r...
Autores principales: | Rao, P. Narasimha, Suneetha, Sujai, Rathod, Santoshdev P., Narang, Tarun, Dogra, Sunil, Singal, Archana, Gupta, Sunilkumar, Vora, Rita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9549560/ https://www.ncbi.nlm.nih.gov/pubmed/36226023 http://dx.doi.org/10.4103/idoj.idoj_683_21 |
Ejemplares similares
-
The Dermlep Study Part 2: Results of a Nation-Wide Survey of Dermatologists' Access to Quality Leprosy Services at their Clinics and Hospitals in India
por: Rao, P. Narasimha, et al.
Publicado: (2020) -
The DermLep Study I: Results of Prospective Nation-Wide Survey of the Number & Profile of Leprosy Patients seen by Dermatologists in India
por: Rao, P. Narasimha, et al.
Publicado: (2020) -
Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by SIG Leprosy (IADVL Academy)
por: Rathod, Santoshdev, et al.
Publicado: (2020) -
Updates on Management of Leprosy in the Context of COVID-19 Pandemic: Recommendations by IADVL SIG Leprosy
por: Bhardwaj, Abhishek, et al.
Publicado: (2021) -
Global leprosy program: Does it need uniform-multi-drug therapy now?
por: Rao, P. Narasimha, et al.
Publicado: (2015)